Drug Patent Watch

OCTOBER 10, 2024

China has emerged as a significant player in the global generic drug active pharmaceutical ingredient (API) market. The country’s vast production capacity, low costs, and strategic location have made it an attractive destination for pharmaceutical companies seeking to source APIs.

Marketing 115

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 115

Drug Patent Watch

DECEMBER 10, 2024

The pharmaceutical industry has undergone significant changes over the past decade, with a growing trend towards outsourcing key aspects of research, development, and manufacturing to third-party vendors. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48

Drug Development 94

Drug Development Compliance Pharmaceutical Companies Drugs 94

Drug Patent Watch

FEBRUARY 27, 2025

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. This is a nightmare scenario for any pharmaceutical company, and it's a reality that many face every day.

Marketing 52

Marketing Drugs Regulations Pharmaceutical Companies 52

Drug Patent Watch

OCTOBER 21, 2024

The pharmaceutical industry is a significant contributor to the global economy, with a substantial portion of its production costs incurred during the development stage. The filing of drug patents in emerging markets is a critical aspect of this protection, as it ensures that companies can recoup their investments and… Source

Marketing 105

Marketing Drugs Pharmaceuticals Production 105

Drug Patent Watch

SEPTEMBER 26, 2024

The generic drug market is a complex and dynamic environment where multiple factors influence the availability, quality, and pricing of generic drugs. Conducting an effective market analysis is crucial for pharmaceutical companies, policymakers, and healthcare professionals to understand the market dynamics and make informed decisions.

Marketing 105

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 105

Drug Patent Watch

OCTOBER 30, 2024

The pharmaceutical industry is known for its complex regulatory environment and lengthy product development processes. These patents can provide opportunities for companies to bring new products to market at a lower cost and with reduced development time.

Pharmaceuticals 104

Pharmaceuticals Production Drugs Marketing 104

Drug Patent Watch

DECEMBER 12, 2024

This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. Understanding the Pharmaceutical Market Dynamics The pharmaceutical industry is a complex ecosystem where branded drugs and generics coexist, each playing a vital role in patient care and market dynamics.

Licensing 94

Licensing Licensing Drugs Clinical Trials 94

Drug Patent Watch

JULY 1, 2024

Lipitor’s marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand […] Source

Marketing 104

Marketing Pharmaceuticals 104

Drug Patent Watch

SEPTEMBER 30, 2024

Patent expirations have a significant impact on the pharmaceutical industry, particularly on the generic drug market. When a drug’s patent expires, other manufacturers can produce and market generic versions of the drug, leading to increased competition and lower prices.

Marketing 105

Marketing Drugs Pharmaceuticals 105

Drug Patent Watch

APRIL 17, 2025

"Patent Use Codes: The Hidden Language of Pharmaceutical Innovation As a healthcare professional, have you ever wondered what lies behind the complex world of patent use codes? In this comprehensive analysis, we delve into the world of patent use codes and explore their significance in the pharmaceutical industry.

Pharmaceuticals 54

Pharmaceuticals Production Marketing 54

Drug Patent Watch

JANUARY 30, 2025

Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. But with the ever-changing landscape of the industry, it can be challenging to stay ahead of the competition.

Marketing 54

Marketing Drugs Production Pharmaceuticals 54

Drug Patent Watch

NOVEMBER 11, 2024

Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.

Pharmaceutical Companies 105

Pharmaceutical Companies Drugs Pharmaceuticals Marketing 105

Drug Patent Watch

DECEMBER 11, 2024

The pharmaceutical industry, particularly the generic drug sector, faces significant challenges in adopting sustainable practices. Addressing Competition and Market Dynamics The lack of competition in the generic drug market contributes to price hikes and shortages. GREENER Pharmaceuticals for More Sustainable Healthcare.

Drug Development 98

Drug Development Compliance Drugs Pharmaceuticals 98

Drugs.com

MARCH 11, 2024

a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a. MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In

Trials 130

Trials Marketing Drugs Pharmaceuticals 130

DrugBank

OCTOBER 4, 2024

Deal Structuring Deal structuring in pharmaceutical M&A requires a balance of financial, legal, and strategic considerations. Intellectual Property Valuation Valuing intellectual property (IP) assets is a critical component of pharmaceutical M&A, as these assets often represent a significant portion of a company's value.

Pharmaceuticals 98

Pharmaceuticals Pharmaceutical Companies Therapies Marketing 98

Drug Patent Watch

JULY 10, 2024

This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […] Source

Marketing 105

Marketing Pharmaceuticals Research 105

Drug Patent Watch

AUGUST 8, 2023

A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding.

Marketing 94

Marketing Pharmaceuticals Drugs 94

Drug Patent Watch

DECEMBER 8, 2024

The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceutical companies.

Biosimilars 98

Biosimilars Pharmaceutical Companies Drugs Pharmaceuticals 98

thought leadership

APRIL 10, 2025

Explore key steps to successfully enter the European pharmaceutical market, including navigating regulatory frameworks, ensuring quality compliance, and obtaining Wholesale Distribution Authorization.

Marketing 52

Marketing Pharmaceuticals Compliance Science 52

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. “Pharmacognosy is the bridge between traditional medicine and modern pharmaceutical science, offering a treasure trove of potential new drugs waiting to be discovered.”

Drugs 97

Drugs Drug Development Pharmaceuticals Production 97

Drug Patent Watch

JULY 2, 2024

The pharmaceutical industry is a high-stakes arena where innovation, investment, and intellectual property (IP) protection intersect. One of the most […] Source

Marketing 105

Marketing Pharmaceuticals 105

Drug Patent Watch

FEBRUARY 11, 2025

The Dark Side of Innovation: How Companies Use Drug Patents to Block Competitors As we celebrate the breakthroughs in medical research and the development of life-saving treatments, it's essential to acknowledge the complex landscape of pharmaceutical innovation. One of the most effective tools in their arsenal is the use of drug patents.

Drugs 94

Drugs Treatment Marketing Production 94

Drug Patent Watch

DECEMBER 30, 2024

This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market. New Drug Application (NDA) : Needed for marketing approval of new drugs.

Drug Development 52

Drug Development Clinical Pharmacology Clinical Trials Pharmaceutical Companies 52

Drug Patent Watch

AUGUST 24, 2023

The Generating Antibiotic Incentives Now Act provides for five years of market… The post Pharmaceutical companies with the most ‘Antibiotic GAIN Act’ drugs appeared first on DrugPatentWatch - Make Better Decisions. This chart shows the companies which have received the most GAIN Act exclusivities in the past five years.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceuticals Drugs Marketing 96

Drug Patent Watch

DECEMBER 10, 2024

” These dense webs of overlapping patent rights can significantly impact innovation, market entry, and competition across various industries and countries. Easier market entry: Less dense thickets may make it easier for new players to enter markets. may create higher barriers to entry for new innovators.

Licensing 98

Licensing Licensing International Marketing 98

Fierce BioTech

MARCH 19, 2024

Cookieless Marketing of Pharmaceuticals Requires Real-World Data Pharma ads face uncertainty with fading third-party cookies. Adapting to cookieless marketing means integrating real-world data into all campaign phases, demanding close collaboration and reliance on new data sources for effective targeting. Download now.

Marketing 52

Marketing Pharmaceuticals 52

SCIENMAG: Medicine & Health

JUNE 16, 2023

Firstly, according to the proposal for the reform of EU pharmaceutical legislation, there are still considerable differences in access between countries. The European Commission’s stated aim is to improve access to innovative drugs at the national level throughout the EU.

Pharmaceuticals 68

Pharmaceuticals Marketing Drug Development Drugs 68

Drug Patent Watch

FEBRUARY 13, 2025

The Unsung Heroes of Generic Drug Development: The Power of Partnerships As we navigate the complex landscape of pharmaceuticals, it's easy to overlook the crucial role that partnerships play in bringing affordable, life-saving medications to market. When it comes to developing generic drugs, partnerships can take many forms.

Drug Development 72

Drug Development Drugs Pharmaceutical Companies Treatment 72

Fierce BioTech

NOVEMBER 22, 2024

AI in Pharma: Benefits, Risks and the Road Ahead AI is revolutionizing the drug development process, streamlining and accelerating every stage, from research to approval and marketing. This whitepaper explores the benefits and risks of AI in the pharmaceutical industry and examines its future.

Drug Development 52

Drug Development Pharmaceuticals Marketing Research 52

Drug Patent Watch

JANUARY 15, 2025

The pharmaceutical industry is highly dynamic, with frequent filings and updates that require timely access to information[2]. Limited Search Filters While Google Patents offers basic search functionalities, it lacks advanced filters specific to pharmaceuticals. Implications for Pharmaceutical Stakeholders 1.

Drugs 54

Drugs Pharmaceuticals Engineering Research 54

Cytel

MAY 7, 2024

Here we explore the evolution and impact of market exclusivity policies in the EU and US, highlighting their role in fostering innovation and accessibility in rare disease treatment. Market exclusivity for orphan drugs traces back to the early 1980s in the United States, with the landmark Orphan Drug Act of 1983.

Marketing 59

Marketing Production Drugs Disease 59

Drug Channels

SEPTEMBER 14, 2021

On October 5, 2021, Drug Channels Institute will release The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. This report—our twelfth edition— remains the most comprehensive, fact-based tool for understanding and analyzing the large and growing U.S. to 1:30 p.m.

Pharmaceuticals 94

Pharmaceuticals Drugs Marketing 94

LifeSciVC

NOVEMBER 28, 2023

Market conditions like this are demoralizing in the worst way. Furthermore, to make matters even more complicated, that same summer, markets had already turned sour, and the sentiment was darkening by the day. The biotech equity markets had effectively shut off the idea of an IPO (which was one of several paths we had mapped out).

Marketing 91

Marketing FDA Pharma Companies Government 91

Fierce BioTech

APRIL 4, 2025

The integration of AI-powered market intelligence offers pharmaceutical companies a competitive edge by enabling real-time insights, predictive analytics, and strategic decision-making. Join us to gain valuable insights into how pharmaceutical companies can leverage AI to achieve more with less.

Marketing 52

Marketing Pharmaceutical Companies Pharmaceuticals 52

Fierce BioTech

AUGUST 7, 2024

The Unfiltered Truth about AI & Pharma Marketing dwunderlin Wed, 08/07/2024 - 12:04 Wed, 09/04/2024 - 14:00 Resource Type Webinar Chris Cullmann Doug Barr Promotion Start Thu, 08/08/2024 - 15:00 Promotion End Sat, 02/08/2025 - 15:00 Duration 60 Minutes You need to know where artificial intelligence disrupts the pharmaceutical marketing norms.

Marketing 52

Marketing Pharmaceutical Companies Pharmaceuticals Production 52

Drug Patent Watch

MARCH 17, 2025

Unlock the Secrets to a Successful Generic Drug Launch Are you a pharmaceutical executive looking to bring a generic version of a popular medication to market? In today's highly competitive pharmaceutical industry, generic drug launches can be a game-changer for companies looking to increase market share and revenue.

Compliance 59

Compliance Drugs Marketing Pharmaceuticals 59

PPD

NOVEMBER 11, 2024

As a result, biopharma and biotech companies working to bring their drug pipelines to the market require deep expertise from trusted partners to help deliver critical therapies for their patients. According to the United Nation’s 2024 World Population Prospects data, the global population of those 65 years old and over will grow from 0.8

Drug Development 97

Drug Development Clinical Trials Drugs Small Molecule 97